報價延遲最少15分鐘:2025/02/23 02:56 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
42.71 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.17/3.76
|
|
企業價值
3.01B
|
| 資產負債 |
|
每股賬面淨值
58.57
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
1.71B
|
|
每股收益
29.21
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/23 02:56 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment. |